Skip to content

US · BGMS · MEDICAL - PHARMACEUTICALS

Bio Green Med Solution, Inc. (BGMS) intrinsic value and stock valuation

$0.55as of 2026-11-21 · Mkt cap 2.27M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Bio Green Med Solution, Inc. DCF and intrinsic value

InvestorsCraft values BGMS with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from BGMS’s statements →

Bio Green Med Solution, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Pharmaceuticals Kuala Lumpur, LF 592000 bgmsglobal.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$750K
20112025
Net income
-$-3M
20112025
Free cash flow
-$-4.77M
20112025
Total equity
$6.84M-27.1% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$750K$40K$420K$0.00$0.00
Operating income-$-8.43M-$-12M-$-25.45M-$-27.66M-$-22.39M
Net income-$-3M-$-11.21M-$-22.55M-$-21.2M-$-18.46M
EPSd-$-1.37M-$-560.5M———
Operating cash flow-$-4.77M-$-7.99M-$-16.11M-$-20.83M-$-18.54M
Capital expenditure$0.00$0.00-$-10K-$-10K-$-30K
Free cash flow-$-4.77M-$-7.99M-$-16.12M-$-20.83M-$-18.57M
Total assets$8.19M$4.09M$8.8M$28.1M$43.1M
Total debt$0.00$0.00$40K$110K$30K
Net debt-$-3.5M-$-3.14M-$-3.34M-$-18.24M-$-36.53M
Total equity$6.84M-$-2.17M$610K$20.4M$37.7M
Cash and short-term investments$3.5M$3.14M$3.38M$18.3M$36.6M
Income statement
20252024202320222021
Revenue$750K$40K$420K$0.00$0.00
Cost of revenue$610K$10K$30K$30K$40K
Gross profit$140K$40K$420K-$-30K-$-40K
Research and development expenses$850K$6.66M$19.2M$20.3M$14.9M
Selling, general and administrative expenses$7.72M$5.39M$6.72M$7.38M$7.46M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$8.56M$12.1M$25.9M$27.7M$22.4M
Cost and expenses$9.17M$12.1M$25.9M$27.7M$22.4M
Interest income$60K$10K$270K$210K$20K
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$10K$10K$30K$30K$40K
Ebitda-$-8.42M-$-12M-$-25.42M-$-27.62M-$-22.35M
Operating income-$-8.43M-$-12M-$-25.45M-$-27.66M-$-22.39M
Total other income/expenses, net$5.44M$10K-$-100K$1.74M$200K
Income before tax-$-2.99M-$-11.99M-$-25.55M-$-25.91M-$-22.18M
Income tax expense$10K-$-780K-$-3M-$-4.72M-$-3.73M
Net income-$-3M-$-11.21M-$-22.55M-$-21.2M-$-18.46M
Weighted average shares outstanding$2.19M$20K$0.00$0.00$0.00
Weighted average diluted shares outstanding$2.19M$20K$0.00$0.00$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$3.5M$3.14M$3.38M$18.3M$36.6M
Net receivables$1.26M$240K$2.93M$4.66M$4.3M
Inventory$1.38M$0.00$0.00$0.00$0.00
Total current assets$6.26M$3.67M$7.44M$24.4M$40.9M
Property, plant and equipment, net$150K$10K$100K$170K$90K
Goodwill and intangible assets$1.57M$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$1.93M$420K$1.36M$3.64M$2.19M
Total assets$8.19M$4.09M$8.8M$28.1M$43.1M
Accounts payable$620K$4.6M$3.54M$2.56M$2.12M
Short-term debt$0.00$0.00$0.00$0.00$0.00
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$1.33M$6.27M$8.16M$7.51M$5.41M
Long-term debt$0.00$0.00$40K$110K$30K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$10K$0.00$40K$110K$30K
Capital lease obligations$0.00$0.00$40K$110K$30K
Total liabilities$1.34M$6.27M$8.2M$7.62M$5.44M
Common stock$10K$10K$0.00$4.5M$10K
Retained earnings-$-454.41M-$-439.49M-$-428.28M-$-405.73M-$-384.53M
Accumulated other comprehensive income (loss)-$-40K-$-890K-$-910K-$-1.32M-$-750K
Total equity$6.84M-$-2.17M$610K$20.4M$37.7M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$40K$110K$30K
Net debt-$-3.5M-$-3.14M-$-3.34M-$-18.24M-$-36.53M
Cash flow statement
20252024202320222021
Net income-$-3M-$-11.21M-$-22.55M-$-21.2M-$-18.46M
Depreciation and amortization$10K$10K$30K$30K$40K
Stock-based compensation$2.33M$590K$1.47M$1.51M$1.16M
Change in working capital-$-9.06M$2.62M$4.94M-$-1.17M-$-1.28M
Accounts receivable-$-1.26M$0.00$0.00$0.00$0.00
Inventory-$-1.38M$0.00$0.00$0.00$0.00
Accounts payable-$-10.51M-$-1.81M$300K$2.58M$3.02M
Net cash provided by operating activities-$-4.77M-$-7.99M-$-16.11M-$-20.83M-$-18.54M
Investments in property, plant and equipment$0.00$0.00-$-10K-$-10K-$-30K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$0.00$0.00-$-10K-$-10K-$-30K
Common stock issued$6.42M$6.21M$1.05M$3.2M$17.4M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-60K$0.00-$-200K-$-200K-$-200K
Net cash used for financing activities$5.26M$7.82M$850K$3M$21.7M
Net change in cash$370K-$-240K-$-14.97M-$-18.21M$3.15M
Cash at end of period$3.5M$3.14M$3.38M$18.3M$36.6M
Operating cash flow-$-4.77M-$-7.99M-$-16.11M-$-20.83M-$-18.54M
Capital expenditure$0.00$0.00-$-10K-$-10K-$-30K
Free cash flow-$-4.77M-$-7.99M-$-16.12M-$-20.83M-$-18.57M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Bio Green Med Solution, Inc.

        Bio Green Med Solution, Inc. (BGMS) operates as a multifaceted company, with active involvement in both the fire protection and biopharmaceutical industries. The organization recently broadened its capabilities by completing the acquisition of Fitters Sdn. Bhd., a Malaysian firm known for its fire safety products and services. BGMS is committed to driving progress in biopharmaceutical research and developing cutting-edge fire safety solutions, striving to deliver enduring value to its investors.

        CEO
        Sing Ee Wong
        Employees
        12
        Beta
        -0.37

        Explore

        Frequently asked questions

        What is the intrinsic value of Bio Green Med Solution, Inc. (BGMS)?

        InvestorsCraft does not currently publish an intrinsic value for BGMS. How the IC value is calculated.

        Is BGMS undervalued?

        InvestorsCraft does not publish an undervaluation signal for BGMS at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.